Alithea Genomics raises CHF 6.9 M

Alithea Genomics develops sample-preparation kits for large-scale RNA sequencing (BRB-seq, DRUG-seq). It has added CHF 3 million to its seed round, bringing it to CHF 6.9 million, to commercialise its 1,536-well DRUG-seq kits.

Announced on
Round
Seed
Amount
CHF 6.9 M
Location
Epalinges, canton of Vaud
Sector
Biotech & life sciences

Investors

Preparing a similar round?

The diagnostic shows you the instruments and investors that fit your stage.

Start the diagnostic